Management
Hendrik Jan Ankersmit (CEO) is the scientific founder of Aposcience AG. He is full Professor at the Medical University of Vienna at the Vienna General Hospital.
Michael Mildner (Chief Scientific Officer, CSO) is associated professor at the Department of Dermatology, Medical University of Vienna with long lasting experience in skin biology and cutaneous tissue regeneration. He received his PhD from the University of Leiden for his studies on in vitro skin models. His main research interests include wound healing, keratinocyte differentiation epithelial barrier formation as well as exploring mechanisms of tissue regeneration.
Sylwia Gazda-Miarecka (Head of Quality Assurance) is a trained chemist and has more than 16 years of experience as quality manager in the pharmaceutical industry. Most recently she served as Head of Quality Assurance at Kwizda Pharma GmbH.
Nina Langoth-Fehringer (Qualified Person) is a pharmacist with a PhD in pharmaceutical technology and over 20 years of experience in the pharmaceutical industry. She has held Qualified Person roles at several companies, where she was responsible for certification of investigational medicinal products, and product development.
Elena Yzchaki MD (Head of Clinical Development) is a physician and clinical development expert with over 10 years of experience in global clinical research, medical oversight, and safety monitoring within the pharmaceutical and biotech industries. Her expertise includes clinical trial strategy, regulatory compliance, and advancing innovative therapies through patient centred clinical development.
Helmut Hofbauer (Head of Administration)